UNIVERSITY OF WASHINGTON
UNIVERSITY OF WASHINGTON Grant
UNIVERSITY OF WASHINGTON Grant is a funding opportunity from UNIVERSITY OF WASHINGTON, up to 379304, closing November 30, 2027.
Nov 30, 2027
(487d left)Overview
ABSTRACT Management of patients with metastatic non-small cell lung cancer (NSCLC) requires navigation of an increasingly diverse therapeutic landscape. Although immune checkpoint inhibitors (ICI) of anti-programmed cell death 1 (PD1) and its ligand PDL1, in combination with chemotherapy (chemoICI), are standard of…